Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Assets Average (2018 - 2026)

Equillium (EQ) posted quarterly Assets Average of $47.5 million for Q1 2026, up 124.34% year-over-year from $21.2 million in Q1 2025, and up 43.04% quarter-over-quarter from $33.2 million in Q4 2025.

Analysis

Equillium (EQ) Assets Average (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Assets Average for 9 consecutive years, with $47.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Assets Average rose 124.34% year-over-year to $47.5 million; the TTM figure through Mar 2026 stood at $47.5 million (up 124.34% YoY), while the FY2025 annual figure was $28.7 million, down 24.49% from the prior year.
  • Assets Average improved to $47.5 million in Q1 2026 per EQ's latest filing, from $33.2 million in the prior quarter.
  • Across five years, Assets Average topped out at $65.3 million in Q2 2023 and bottomed at $14.6 million in Q2 2025.
  • Historically, Assets Average has averaged $39.4 million across 5 years, with a median of $38.7 million in 2024.
  • Annual changes were most pronounced in 2022 — Assets Average tumbled 77.7% — and 2023, when it jumped 183.21%.
  • Equillium's Assets Average stood at $35.8 million in 2022, then soared by 47.54% to $52.9 million in 2023, then slumped by 43.21% to $30.0 million in 2024, then rose by 10.54% to $33.2 million in 2025, then jumped by 43.04% to $47.5 million in 2026.
  • Business Quant data shows EQ's Assets Average at $47.5 million in Q1 2026, $33.2 million in Q4 2025, and $23.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Equillium 249.33 Mn 249.33 Mn - 60.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.87 Mn
Mar 31, 2026 47.49 Mn
Dec 31, 2025 33.20 Mn
Sep 30, 2025 23.45 Mn
Jun 30, 2025 14.56 Mn
Mar 31, 2025 21.17 Mn
Dec 31, 2024 30.03 Mn
Sep 30, 2024 38.66 Mn
Jun 30, 2024 43.23 Mn
Mar 31, 2024 47.06 Mn
Dec 31, 2023 52.88 Mn
Sep 30, 2023 56.99 Mn
Jun 30, 2023 65.28 Mn
Mar 31, 2023 75.11 Mn
Dec 31, 2022 63.53 Mn
Sep 30, 2022 35.84 Mn
Jun 30, 2022 23.05 Mn
Mar 31, 2022 54.23 Mn
Dec 31, 2021 88.94 Mn
Sep 30, 2021 96.15 Mn